Clinical Trials for Senti Biosciences

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Senti Biosciences

Clinical Trials (2)

NCT06652243
Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma
EARLY_PHASE1Recruiting
12 participants
Started: Nov 18, 2024 · Completed: Oct 31, 2027
1 condition3 sponsors1 location
NCT06325748
SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS
PHASE1Recruiting
21 participants
Started: Apr 22, 2024 · Completed: Aug 31, 2040
3 conditions1 sponsor8 locations